News

MedPage Today1h
CRLs Are the Low-Hanging Fruit of FDA Transparency, Experts Say
For instance, "the backlog of FOIAs ... is enormous," he said. Califf said the FDA has far greater opportunities for improved ...
Juul puede seguir vendiendo sus vapes de tabaco y mentol, dice la FDA
La Administración de Alimentos y Medicamentos (FDA) permitirá que la marca de vapeo Juul mantenga sus cigarrillos ...
GSK’s Blood Cancer Drug Blenrep Fails to Win FDA Panel Support
GSK Plc’s blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting its approval in doubt.
RFK Jr. and other Trump officials embrace psychedelics after FDA setback
For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering ...
FDA-backed metric used to determine effectiveness of rectal cancer drugs may be unreliable, says new study
A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising ...
FDA issues risk warning for nationwide cough syrup recall
Prestige Consumer Healthcare Inc. issued a voluntary recall for more than 10,000 cases of honey cough syrup on June 17.
CURE2h
FDA Grants Orphan Status to Liquid Glioma Treatment SH-110
SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...
Ophthalmology Times3h
FDA accepts for review Aldeyra Therapeutics’ resubmitted New Drug Application for reproxalap
The FDA accepted Aldeyra's resubmitted NDA for reproxalap after previous rejections due to efficacy concerns, despite no ...